REIMBURSEMENT DECISION LANDSCAPE FOR ORPHAN DRUGS ACROSS SIX HTA AGENCIES

被引：0

作者：

Mittal, L. K. ^{[1
]}

Banerjee, P. ^{[2
]}

Kapoor, A. ^{[2
]}

Ligade, V. S. ^{[1
]}

机构：

[1] Manipal Univ, Manipal, Karnataka, India

[2] Optum Global Solut, Noida, India

来源：

VALUE IN HEALTH | 2016年 / 19卷 / 03期

关键词：

D O I：

10.1016/j.jval.2016.03.1032

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PSY93

引用

页码：A257 / A257

页数：1

共 50 条

[1] ANALYSIS OF ORPHAN DRUGS REIMBURSEMENT IN MAJOR EUROPEAN HTA AGENCIES
Houzelot, D.
Heng, C.
Perinaud, A.
[J]. VALUE IN HEALTH, 2016, 19 (07) : A602 - A602
[2] THE REIMBURSEMENT OF ORPHAN DRUGS ACROSS EUROPE
Nixon, F.
[J]. VALUE IN HEALTH, 2008, 11 (06) : A375 - A376
[3] REIMBURSEMENT DECISION LANDSCAPE FOR METASTATIC BREAST CANCER THERAPIES: A COMPARISON OF FACTORS LEADING TO FAVORABLE AND UNFAVORABLE RECOMMENDATIONS ACROSS LEADING HTA AGENCIES
Banerjee, P.
Gupta, J.
Kumar, P.
Kapoor, A.
Mazumder, D.
[J]. VALUE IN HEALTH, 2015, 18 (03) : A6 - A6
[4] The correlation between HTA recommendations and reimbursement status of orphan drugs in Europe
Kawalec, Pawel
Sagan, Anna
Pilc, Andrzej
[J]. ORPHANET JOURNAL OF RARE DISEASES, 2016, 11
[5] The correlation between HTA recommendations and reimbursement status of orphan drugs in Europe
Paweł Kawalec
Anna Sagan
Andrzej Pilc
[J]. Orphanet Journal of Rare Diseases, 11
[6] TRENDS AND KEY DECISION DRIVERS FOR REJECTING AN ORPHAN DRUG SUBMISSION ACROSS FIVE DIFFERENT HTA AGENCIES
Mardiguian, S.
Stefanidou, M.
Sheppard, F.
[J]. VALUE IN HEALTH, 2014, 17 (07) : A438 - A438
[7] ORPHAN DRUGS ASSESSMENT IN GERMANY: A COMPARISON WITH OTHER INTERNATIONAL HTA AGENCIES
Mycka, J.
Dellamano, R.
Lobb, W.
Dellamano, L.
Dalal, N.
[J]. VALUE IN HEALTH, 2015, 18 (07) : A550 - A551
[8] WHY ARE THERE DIFFERENCES IN HTA RECOMMENDATIONS ACROSS COUNTRIES? A SYSTEMATIC COMPARISON OF HTA DECISION PROCESSES FOR A SAMPLE OF ORPHAN DRUGS IN FOUR COUNTRIES
Nicod, E.
[J]. VALUE IN HEALTH, 2014, 17 (07) : A540 - A540
[9] COMPARATIVE ANALYSIS OF THE REIMBURSEMENT LANDSCAPE OF ORPHAN DRUGS ON AN INTERNATIONAL LEVEL
Nozha, S.
[J]. VALUE IN HEALTH, 2015, 18 (07) : A677 - A677
[10] COMPARATIVE ANALYSIS OF HTA DECISIONS, PRICE AND REIMBURSEMENT LEVEL OF ORPHAN DRUGS IN FRANCE AND ITALY
Korchagina, D.
Tavella, F.
Remuzat, C.
Kornfeld, A.
Toumi, M.
[J]. VALUE IN HEALTH, 2014, 17 (07) : A539 - A540

← 1 2 3 4 5 →